Dec 2, 2021 | Webinars & Events
The Hexima Limited Annual General meeting was held on 2 December 2021 at 11am. A copy of the CEO presentation and a recording of the meeting are available below. Due to Government restrictions and public health advice regarding public gatherings during the COVID-19...
Nov 4, 2021 | Webinars & Events
Hexima’s CEO, Mr Michael Aldridge spoke to Sonia Madigan on The Deal Room by The Market Herald regarding its recent capital raise and what to expect next. The Market Herald is the leading source of authoritative breaking stock market news for self-directed...
Nov 1, 2021 | Company News
Hexima is pleased to announce that it has completed the bookbuild for a placement to raise $10.0 million. In addition, Hexima proposes to launch a share purchase plan for Eligible Shareholders in Australia and New Zealand (SPP) to raise up to a further $1.0 million....
Oct 28, 2021 | KOL Interviews
Hexima recently took the opportunity to speak with some of the members of its Scientific Advisory Board about Onychomycosis: the disease, its treatment and the potential for a new therapy like pezadeftide. You can view the insightful responses from Dr Robert Rosen, Dr...
